c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EDT
UTC-4 New York
Blue Chip
Log in
Sign up
CRVS
Corvus Pharmaceuticals, Inc.
stock
NASDAQ
At Close
Oct 5, 2026 3:59:59 PM EDT
10.74
USD
-1.468%
(-0.16)
823,712
10.72
Bid
12.11
Ask
1.39
Spread
Pre-market
After-hours
Oct 5, 2026 4:01:30 PM EDT
10.66
USD
-0.745%
(-0.08)
Overview
Options
Historical
Exchanges
Shorts
News
News
CRVS News
1
/
1
Sep 30, 2026
Day breaks
Sep 30, 2026
04:05 PM EDT
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
·
GlobeNewswire Inc.
stockNASDAQstockNASDAQ